(0 Item)

GCP violations and Site Mistakes commonly found During a FDA Investigator Site Inspection/Audit and how to avoid them

Webinars - GCP violations and Site Mistakes commonly found During a FDA Investigator Site Inspection/Audit and how to avoid them
Webinars

By : Compliance Online

Date : 2011

Location : United States US / Palo Alto

Video 01h 24m
Description :

This GCP training will guide you through key component identification of a good GCP audit program, Investigator awareness, Protocol adherence, The Informed Consent process, Evaluation of subject selection, Inclusion/exclusion criteria, data sampling and audit findings assessments.

Keywords :

GCP Violation, GCP Investigator , FDA inspection, Compliance training, Web Seminar, E-learning

Product/ documentation details
GCP violations and Site Mistakes commonly found During a FDA Investigator Site Inspection/Audit and how to avoid them

Product Type : On Demand Webinar

Author : Charles H Pierce

Video 01h 24m

Languages : English

CP Investigator site audits are a routine and a necessary part of the clinical trial process. If you are participating in a clinical trial or multiple trials as a Principal Investigator, a study coordinator, a monitor, or even as the IRB chances are that you may be audited. This Webinar will cover the most frequently found GCP violations / mistakes that are often found during the audit process.

 

This Webinar will review FDA inspection program details and how to ensure your site is prepared for an inspection. Focus areas would be Key component identification of a good audit program, Investigator awareness, Protocol adherence, The Informed Consent process, Evaluation of subject selection, Inclusion/exclusion criteria, Methods for data sampling and how to assess audit findings and classify significant observations. We will give you helpful hints to help you avoid the common GCP mistakes and hints to enhance the overall audit experience.

 

 

Who Will Benefit:

 

This webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects. Those benefiting the most would be:

 

  • Principal Investigators / Sub-investigators.
  • Safety Nurses.
  • Clinical Research Associates (CRAs) and Coordinators (CRCs).
  • Recruiting staff
  • QA / QC auditors and staff.
  • Clinical Research Data managers

Areas Covered in the Seminar:

 

  • The historical background of why studies are audited and the purpose of audits.
  • The regulatory requirements for the BIMO program.
  • Studies targeted for auditing?
  • How following GCP will end up making you look good to inspectors?
  • How do you prepare for an audit?
  • What Does the Inspector/Auditor look for?
  • What are the common GCP mistakes sites make?
  • How to prevent and detect misconduct and fraud?
  • What happens after an inspection / audit is done?

 

 

Instructor Profile:
 

Charles H. Pierce, MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message (via webinars, lectures and seminars) of Risk Management through knowledge of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. Dr. Pierce serves as an advisor to several clinical research organizations. He has been in the Clinical Research Industry for 20+ years, has been involved in developing Phase I & IIa Clinical Pharmacology Units, Investigator and staff GCP training, and medical monitoring in both drug and device studies.

Bookmark and Share

GCP violations and Site Mistakes commonly found During a FDA Investigator Site Inspection/Audit and how to avoid them

Product Type : On Demand Webinar

Author : Charles H Pierce

Video 01h 24m

Languages : English

Organizer : Compliance Online

ComplianceOnline is a Regulatory Affairs Professionals Society(RAPS) RA Professional Development Portal provider. ComplianceOnline is committed to enhancing the ongoing professional development of regulatory affairs professionals and other stakeholders through appropriate regulatory affairs learning activities and programs ComplianceOnline has agreed to follow RAPS-established operational and educational criteria